Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2001
DOI: 10.1067/mjd.2000.111338
|View full text |Cite
|
Sign up to set email alerts
|

Pseudoporphyria

Abstract: Pseudoporphyria is the term used to describe a photodistributed bullous disorder with clinical and histologic features of porphyria cutanea tarda, but without accompanying biochemical porphyrin abnormalities. Medications, chronic renal failure/dialysis, excessive sun exposure and UVA radiation have all been reported to cause pseudoporphyria. Recognition, diagnosis, and appropriate management of pseudoporphyria are discussed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
127
0
4

Year Published

2008
2008
2017
2017

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 137 publications
(131 citation statements)
references
References 78 publications
0
127
0
4
Order By: Relevance
“…Potential triggers of pseudoporphyria include numerous drugs, including tetracyclines, diuretics, dapsone, cyclosporine A, and retinoids. However, the most common drug known to cause pseudoporphyria is the NSAID naproxen, a derivative of propionic acid [ 4,5 ] . Among adults, females are predominantly affected [ 6 ] .…”
Section: Discussionmentioning
confidence: 99%
“…Potential triggers of pseudoporphyria include numerous drugs, including tetracyclines, diuretics, dapsone, cyclosporine A, and retinoids. However, the most common drug known to cause pseudoporphyria is the NSAID naproxen, a derivative of propionic acid [ 4,5 ] . Among adults, females are predominantly affected [ 6 ] .…”
Section: Discussionmentioning
confidence: 99%
“…N-acetylcysteine is also used in prophylactic therapy of contrast nephropathy as it prevents the increase of oxidative stress after contrast infusion. 1,6,10 We present a case of PP secondary to dialysis with good response to the use of oral N-acetylcysteine. The patient maintained the use of erythropetin and presented improvement of the lesions, suggesting that the condition was not medicamental.…”
Section: Comunicationmentioning
confidence: 99%
“…There are reports of clinical control after the use of oral N-acetylcysteine. [1][2][3][4][5] It is presented here the case of a female patient, aged 32, who had been suffering from Goodpasture's syndrome for five years, evolving into chronic renal failure (anuria) and renal replacement therapy (peritoneal dialysis ) and placed on a transplant waiting list. The patients had been presenting recorrent bullae with hyaline content on the backs on the hands and feet for one year.…”
Section: Comunicationmentioning
confidence: 99%
See 2 more Smart Citations